Human Lmmunoglobulin

Product Description

The main component of this preparation is human immunoglobulin, which is prepared by cold ethanol fractionation of human plasma from healthy donors. The manufacturing process contains a step of low pH incubation for viral inactivation. It contains a suitable amount of glycine as stabilizer, but does not contain any antiseptic or antibiotic.

Human Immunoglobulin is mainly indicated for the prophylaxis of measles and infectious hepatitis. The use of human immunoglobulin in combination with antibiotics can promote its curative effects on certain severe bacterial and viral infections.

150mg/vial (10%, 1.5ml), 300mg/vial (10%, 3ml)

Sichuan Yuanda Shuyang Pharmaceut.

  • CN
  • 2015
    On CPhI since
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    China

Sichuan Yuanda Shuyang Pharmaceut.

  • CN
  • 2015
    On CPhI since

More Products from Sichuan Yuanda Shuyang Pharmaceut.

  • Human Histaglobulin

    Product Human Histaglobulin

      The main component of this preparation is human histaglobulin, of which the human immunoglobulin is originated from human plasma from healthy donors. The manufacturing process contains a step of low pH incubation for viral inactivation. It contains suitable amounts of sodium thiosulfate and glucose as stabilizers.

      The product is indicated for the prevention and treatment of allergic diseases such as bronchial asthma, allergic dermatosis, nettle rash, etc.

      12mg (2ml)/vial

  • Human Hepatitis B Immunoglobulin

    Product Human Hepatitis B Immunoglobulin

    The manufacturing process for human hepatitis B immunoglobulin contains a step of low pH incubation for viral inactivation. It contains a suitable amount of glycine as stabilizer, but does not contain any antiseptic or antibiotic.

    Indications:
    -Post-exposure prophylaxis should be considered following percutaneous or permucosal exposure to HBsAg-positive or suspected HBsAg-positive material, for example, by needle, oral ingestion or sexual exposure.
    -For prophylaxis in infants born to HBsAg-positive mothers. Mainly designated for prophylaxis of hepatitis B and suitable for use in Liver transplantation
    Strength: 400IU/vial (4ml) ,200IU/vial (2ml),100 IU/vial(1ml) -Post-exposure prophylaxis in persons who did not receive prior vaccinations, or whose prior vaccination regimen is incomplete, or when hepatitis B antibody levels are inadequate (<10 IU/L).

  • Human Albumin

    Product Human Albumin

    The main component of this preparation is human albumin, which is prepared by cold ethanol fractionation of human plasma from healthy donors. The manufacturing process of human albumin contains a step of heating the final solution at 60℃ for 10 hours to inactivate the viruses present in it. It contains a suitable amount of sodium caprylate as stabilizer, but does not contain any antiseptic or antibiotic.
    Indications: -Shock caused by blood loss, trauma and burn.
    -Increased intracranial pressure caused by cerebral edema and injury.
    -Edema or ascites caused by hepatic cirrhosis and nephrosis.
    -Prevention and treatment of hypoproteinemia.
    -Hyperbilirubinemia in new born babies.
    -Supplementary treatment of cardiopulmonary shunt, fire burn and hemodialysis; treatment of adult respiratory distress syndrome.Strength: 20g/vial (100ml),12.5g/vial (62.5ml),10g/vial (50ml),5g/vial (25ml),2g/vial (10ml)
  • Human Tetanus Immunoglobulin

    Product Human Tetanus Immunoglobulin

    The main component of this preparation is human tetanus immunoglobulin, which is prepared by cold ethanol fractionation of human plasma from donors immunized against tetanus. Donations are selected on the basis that they contain high titers of antibodies against tetanus. The manufacturing process for human rabies immunoglobulin contains a low pH incubation step for viral inactivation. It contains a proper amount of glycine as stabilizer, but does not contain any antiseptic and antibiotic.

    Human tetanus immunoglobulin is mainly indicated for the prophylaxis and treatment of tetanus, especially suitable for use in individuals hypersensitive to tetanus antitoxin (TAT).

    250 IU/vial (100 IU/ml, 2.5ml), 500 IU/vial (100 IU/ml, 5ml)

  • Human Rabies Lmmunoglobulin

    Product Human Rabies Lmmunoglobulin

    Human rabies immunoglobulin is prepared by cold ethanol fractionation of human plasma from donors immunized against rabies. The manufacturing process for human rabies immunoglobulin contains a low pH incubation step for viral inactivation. It contains a proper amount of glycine as stabilizer, but does not contain any antiseptic and antibiotic.
    Human rabies immunoglobulin is mainly indicated for passive immunization in persons with bite wounds or scratch injuries caused by a rabid dog or other rabid animals. Any person with suspected rabies exposure shall use rabies vaccine and human rabies immunoglobulin in combination. If the patient has been vaccinated against rabies and has sufficient titers of anti-rabies antibodies, he/she shall be revaccinated against rabies instead of using this product.
    100 IU/vial (100 IU/ml, 1ml), 200 IU/vial (100IU/ml, 2ml), 500 IU/vial (100 IU/ml, 5ml)


  • Human Immunoglobulin (Ph4) For Intravenous Injection

    Product Human Immunoglobulin (Ph4) For Intravenous Injection

    The main component of this preparation is human immunoglobulin, which is prepared by cold ethanol fractionation of human plasma from healthy donors. The manufacturing process contains a step to remove anticomplementary activity and a dual viral inactivation process. 
    Indications

    1. Primary agammaglobulinemia, such as X-linked hypogammaglobulinemia, common variant immunodeficiency diseases, immunoglobulin G subclass deficiency, etc.

    2. Secondary immunoglobulin deficiency diseases, such as severe infection, septicemia of newborn, etc

    3. Autoimmune diseases, such as primary thrombocytopenic purpura, Kawasaki disease.
    Specifications

    0.5g/vial (5%, 10ml), 1 g/vial (5%, 20ml), 1.25g/vial (5%, 25ml), 2.5g/vial (5%, 50ml), 5gvial (5%, 100ml), 10g/vial (5%, 200ml).

     

  • Human Hepstitis B Immunoglobulin (Ph4) For Intrevenous Injection

    Product Human Hepstitis B Immunoglobulin (Ph4) For Intrevenous Injection

    Major constituent: Human hepatitis B immunoglobulin; Subsidiary material: Maltose

    Indications:Use of the product in combination with lamivudine can prevent patients with HBV (hepatitis B virus)-related diseases from being re-infected with HBV after liver transplantation.

    Strengths:2000 IU (50 IU/ml, 40 ml)

Recommended products